vs
Side-by-side financial comparison of BIOCRYST PHARMACEUTICALS INC (BCRX) and BASSETT FURNITURE INDUSTRIES INC (BSET). Click either name above to swap in a different company.
BIOCRYST PHARMACEUTICALS INC is the larger business by last-quarter revenue ($156.4M vs $80.1M, roughly 2.0× BASSETT FURNITURE INDUSTRIES INC). On growth, BIOCRYST PHARMACEUTICALS INC posted the faster year-over-year revenue change (7.5% vs 5.9%). Over the past eight quarters, BIOCRYST PHARMACEUTICALS INC's revenue compounded faster (19.6% CAGR vs -10.7%).
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir (Rapivab) was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.
Bassett Furniture Industries, Inc. is a furniture manufacturer and retailer, headquartered in Bassett, Virginia, United States. It was founded in 1902 by John D. Bassett, Charles C. Bassett, Samuel H. Bassett, and Reed L. Stone. Bassett Furniture is one of the oldest furniture manufacturers in Virginia. The company began when the founders, operating a family sawmill in the foothills of the Blue Ridge Mountains, decided to use surplus lumber to produce bedroom furniture. According to oral hist...
BCRX vs BSET — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $156.4M | $80.1M |
| Net Profit | — | $801.0K |
| Gross Margin | — | 56.2% |
| Operating Margin | 13.6% | 0.7% |
| Net Margin | — | 1.0% |
| Revenue YoY | 7.5% | 5.9% |
| Net Profit YoY | — | 117.8% |
| EPS (diluted) | $0.00 | $0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $156.4M | — | ||
| Q4 25 | $406.6M | — | ||
| Q3 25 | $159.4M | $80.1M | ||
| Q2 25 | $163.4M | $84.3M | ||
| Q1 25 | $145.5M | — | ||
| Q4 24 | $131.5M | $92.1M | ||
| Q3 24 | $117.1M | $75.6M | ||
| Q2 24 | $109.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | $245.8M | — | ||
| Q3 25 | $12.9M | $801.0K | ||
| Q2 25 | $5.1M | $1.9M | ||
| Q1 25 | $32.0K | — | ||
| Q4 24 | $-26.8M | $508.0K | ||
| Q3 24 | $-14.0M | $-4.5M | ||
| Q2 24 | $-12.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | 97.7% | — | ||
| Q3 25 | 98.6% | 56.2% | ||
| Q2 25 | 98.3% | 55.6% | ||
| Q1 25 | 96.9% | — | ||
| Q4 24 | 95.4% | 55.7% | ||
| Q3 24 | 97.3% | 53.0% | ||
| Q2 24 | 98.4% | — |
| Q1 26 | 13.6% | — | ||
| Q4 25 | 64.0% | — | ||
| Q3 25 | 18.6% | 0.7% | ||
| Q2 25 | 18.2% | 3.0% | ||
| Q1 25 | 14.6% | — | ||
| Q4 24 | -3.4% | -1.3% | ||
| Q3 24 | 6.6% | -8.4% | ||
| Q2 24 | 8.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | 60.5% | — | ||
| Q3 25 | 8.1% | 1.0% | ||
| Q2 25 | 3.1% | 2.3% | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | -20.4% | 0.6% | ||
| Q3 24 | -12.0% | -6.0% | ||
| Q2 24 | -11.6% | — |
| Q1 26 | $0.00 | — | ||
| Q4 25 | $1.13 | — | ||
| Q3 25 | $0.06 | $0.09 | ||
| Q2 25 | $0.02 | $0.22 | ||
| Q1 25 | $0.00 | — | ||
| Q4 24 | $-0.13 | $0.07 | ||
| Q3 24 | $-0.07 | $-0.52 | ||
| Q2 24 | $-0.06 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $259.0M | $54.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $165.7M |
| Total Assets | $465.1M | $324.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $259.0M | — | ||
| Q4 25 | $274.7M | — | ||
| Q3 25 | $212.9M | $54.6M | ||
| Q2 25 | $260.0M | $59.8M | ||
| Q1 25 | $295.1M | — | ||
| Q4 24 | $320.9M | $59.9M | ||
| Q3 24 | $96.8M | $56.2M | ||
| Q2 24 | $78.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-119.2M | — | ||
| Q3 25 | $-387.9M | $165.7M | ||
| Q2 25 | $-421.6M | $166.8M | ||
| Q1 25 | $-451.9M | — | ||
| Q4 24 | $-475.9M | $167.3M | ||
| Q3 24 | $-468.6M | $165.0M | ||
| Q2 24 | $-475.6M | — |
| Q1 26 | $465.1M | — | ||
| Q4 25 | $514.2M | — | ||
| Q3 25 | $446.4M | $324.2M | ||
| Q2 25 | $457.2M | $331.3M | ||
| Q1 25 | $480.0M | — | ||
| Q4 24 | $490.4M | $341.2M | ||
| Q3 24 | $491.3M | $335.9M | ||
| Q2 24 | $472.4M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-1.2M |
| Free Cash FlowOCF − Capex | — | $-2.6M |
| FCF MarginFCF / Revenue | — | -3.3% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | -1.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $292.0M | — | ||
| Q3 25 | $41.6M | $-1.2M | ||
| Q2 25 | $41.3M | — | ||
| Q1 25 | $-27.5M | — | ||
| Q4 24 | $-5.2M | — | ||
| Q3 24 | $8.2M | $5.4M | ||
| Q2 24 | $-1.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $291.2M | — | ||
| Q3 25 | $40.3M | $-2.6M | ||
| Q2 25 | $41.1M | — | ||
| Q1 25 | $-27.7M | — | ||
| Q4 24 | $-5.9M | — | ||
| Q3 24 | $8.2M | $2.8M | ||
| Q2 24 | $-1.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | 71.6% | — | ||
| Q3 25 | 25.3% | -3.3% | ||
| Q2 25 | 25.2% | — | ||
| Q1 25 | -19.0% | — | ||
| Q4 24 | -4.5% | — | ||
| Q3 24 | 7.0% | 3.7% | ||
| Q2 24 | -1.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.8% | 1.8% | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | 3.5% | ||
| Q2 24 | 0.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.19× | — | ||
| Q3 25 | 3.23× | -1.47× | ||
| Q2 25 | 8.12× | — | ||
| Q1 25 | -859.91× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCRX
| ORLADEYO | $148.3M | 95% |
| Other revenues | $5.0M | 3% |
| License revenue | $3.0M | 2% |
BSET
| Retail Segment | $51.9M | 65% |
| Bassett Custom Upholstery | $18.7M | 23% |
| Accessories Mattresses And Other | $6.9M | 9% |
| Bassett Custom Wood | $2.7M | 3% |
